Ipca Laboratories Ltd Share Price
(IPCALAB)
₹1442.7
as on 02:17PM, 24 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 1.23 % |
3 Month Return | -2.97 % |
1 Year Return | + 9.18 % |
Market Stats | |
Previous Close | ₹1,470.90 |
Open | ₹1,443.20 |
Volume | 1.26L |
Upper Circuit | ₹1,765.00 |
Lower Circuit | ₹1,176.80 |
Market Cap | ₹37,317.35Cr |
P/E Ratio
51.14
PEG Ratio
7.86
Market Cap
₹37,317.35 Cr
P/B Ratio
4.95
EPS
20.86
Dividend Yield
0.32
Sector
Pharmaceuticals
ROE
9.81
based on 20 analysts
65.00%
Buy
20.00%
Hold
15.00%
Sell
Based on 20 analysts offering long term price targets for Ipca Laboratories Ltd. An average target of ₹1632.25
Source: S&P Global Market Intelligence
Ipca Laboratories Ltd price forecast by 20 analysts
Upside of10.97%
High
₹1918
Target
₹1632.25
Low
₹900
Ipca Laboratories Ltd target price ₹1632.25, a slight upside of 10.97% compared to current price of ₹1442.7. According to 20 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Ipca Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2027:46.81%
Forecast
Actual
Including amortisation and stock based compensations
Ipca Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2027:162.40%
Forecast
Actual
Source: S&P Global Market Intelligence
IPCA Laboratories Shares Plummet Amid Tariff Concerns - 04 Apr, 2025
Ipca Laboratories Gains from Tariff Exemption News - 03 Apr, 2025
Ipca Laboratories Announces Facility Sale and Acquisition - 28 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 59.59 Cr → 248.14 Cr (in ₹), with an average increase of 30.9% per quarter
Price Rise
In the last 7 days, IPCALAB stock has moved up by 4.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.72% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 55.3% return, outperforming this stock by 46.2%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 143.9% return, outperforming this stock by 96.7%
Retail Holding Down
Retail Investor have decreased holdings from 8.53% to 8.46% in Mar 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 2.38K Cr → 2.26K Cr (in ₹), with an average decrease of 4.9% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 11.07% to 10.76% in Mar 2025 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.72% | 0.00 | |
Foreign Institutions | 10.76% | 0.00 | |
Mutual Funds | 29.63% | 0.00 | |
Retail Investors | 8.46% | 0.00 | |
Others | 6.43% | 0.00 |
Ipca Laboratories Ltd in the last 5 years
Lowest (18.72x)
October 10, 2019
Today (51.14x)
April 23, 2025
Industry (53.87x)
April 23, 2025
Highest (65.89x)
September 25, 2024
Ipca Laboratories Ltd’s net profit jumped 37.95% since last year same period to ₹248.14Cr in the Q3 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated 8.13% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Ipca Laboratories Ltd has declared dividend of ₹2 - translating a dividend yield of 0.27%.
Read More about DividendsBearish
Neutral
Bullish
Ipca Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹37,317.35 Cr | 16.44% | 0.58 | ₹529 Cr | ₹7,705 Cr | |
BUY | ₹14,832.47 Cr | -2.97% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
BUY | ₹73,054.83 Cr | 19.93% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
HOLD | ₹87,341.11 Cr | 31.52% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
BUY | ₹64,748.75 Cr | 17.07% | 0.53 | NA | NA |
Organisation | Ipca Laboratories Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Ipca Laboratories Ltd share price today stands at ₹1442.7, Open: ₹1443.2, Previous Close: ₹1470.9, High: ₹1474.2, Low: ₹1437.1, 52 Week High: ₹1755.9, 52 Week Low: ₹1052.
Today's traded volume of Ipca Laboratories Ltd(IPCALAB) is 1.26L.
Today's market capitalisation of Ipca Laboratories Ltd(IPCALAB) is ₹37317.35Cr.
Ipca Laboratories Ltd (IPCALAB) share price is ₹1442.7. It is down -17.84% from its 52 Week High price of ₹1755.9
Ipca Laboratories Ltd (IPCALAB) share price is ₹1442.7. It is up 37.14% from its 52 Week Low price of ₹1052